Estudo avaliou diversos regimes heterólogos de vacinas contra o SARS-CoV-2; não há dados de eficácia, mas houve maior aumento na produção de anticorpos nos participantes 15 e 29 dias depois da dose de reforço com vacinas da Moderna e da Pfizer.
15 Out, 2021 | 16:49hHeterologous SARS-CoV-2 Booster Vaccinations: Preliminary Report – medRxiv
Comentário: Study: Mixing and Matching COVID-19 Booster Shots Is Effective, Safe – U.S. News
Comentário no Twitter
So yes, mRNA vaccines are great at generating antibodies but what does that mean? Where is the efficacy data? How come JnJ gets really great efficacy at preventing symptomatic COVID and severe disease with low antibodies? T-cells? Still much to learn. https://t.co/YwKUyogAhQ
— Daniel Griffin MD PhD (@DanielGriffinMD) October 13, 2021